Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel
Scientists create synthetic form of SBV
Schmallenberg study raises vaccine hopes

Scottish scientists have made a synthetic version of the Schmallenberg virus (SBV) in the laboratory, raising hopes for the development of a vaccine for the disease.

The synthetic version was formed so that scientists were able to study its genetics and how it infects farm animals. They manipulated the virus's genetic sequence so it was more and less severe during the study.

Experiments showed that, if the virus is passed to calves or lambs during pregnancy, it replicates itself in the brain cells and spinal cords of the unborn animals.

Massimo Palmarini and Alan Kohl led the study at the MRC-University of Glasgow Centre for Virus Research.

Professor Palmarini said: "This is the first time we have been able to manipulate the genome of SBV in this way. We now know much more about how the virus causes the disease than we did a couple of months ago."

SBV was first discovered in Germany in November 2011 and has since spread to the UK, via midges that were blown over from the continent. The virus is now carried by native midges, and has affected about 1,000 farms across England and Wales.

An SBV vaccine is currently undergoing tests for European approval.

Become a member or log in to add this story to your CPD history

Greyhound Board announces change to vaccination guidance

News Story 1
 The Greyhound Board of Great Britain has published new vaccination guidance, with all greyhounds registered from 1 January, 2027 required to have the L4 leptospirosis vaccination, rather than L2.

The change comes in response to the reduced availability of the 'L2' Leptospirosis vaccine across the UK, and aims to support best biosecurity practice across the racing greyhound population.

GBGB veterinary director Simon Gower, said "While rare, Leptospirosis is a serious infectious disease that can affect both dogs and humans, so it is vital that we offer our greyhounds the broadest possible protection.  

Click here for more...
News Shorts
Free webinar explores congenital heart disease in dogs

A free webinar is to provide veterinary professionals, dog breeders and pet owners an new insights into congenital heart disease.

Chris Linney, a cardiology specialist and Veterinary Cardiovascular Society (VSC) member, will present the webinar from 7.00pm to 8.30pm on Wednesday, 12 November.

Dr Linney will explore the types, causes and clinical presentation of congenital heart conditions. This will include diagnostic approaches, treatment pathways and emerging research opportunities.

The session is the third to be organised by The Kennel Club, with the VCS, following an introductory webinar and a talk on acquired heart disease. Dr Linney's webinar consists of a one-hour presentation, followed by a 30-minute question and answer session.

Dr Linney said: "This webinar will be an opportunity to deepen understanding - not just of the diseases themselves, but of how breeders, vets and owners can work together to support affected dogs and improve outcomes for future generations."

Click here to register for the webinar.